Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 269-274

  Xu, Keping ^a   McDermott, Mark ^a   Villanueva, Linda ^b   Schiffman, Rhett M ^b   Hollander, David A ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Bromfenac 0.09 ; Corneal epithelial wound healing; Epithelial toxicity; Ketorolac 0.45 ; Nepafenac 0.1 ; Ocular surgery

Indexed keywords

ACUVAIL; BROMFENAC; KETOROLAC TROMETAMOL; NEPAFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; EX VIVO STUDY; IMAGE ANALYSIS; NONHUMAN; ORGAN CULTURE; SWINE; WOUND HEALING;

EID: 79952846428     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S16778     Document Type: Article

References (27)

1. Payan DG, Katzung BG. Nonsteroidal anti-inflammatory drugs; Nonopioid analgesics; drugs used in gout. In Katzung BG, editor. Basic and Clinical Pharmacology. 6th ed. London, UK; Prentice Hall International; 1995:536-559.
2. Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol. 1996;80(5):480-485.
3. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004;18(7):790-804.
4. Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55(2):108-133.
5. O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care [Erratum in: Curr Med Res Opin. 2005;21(9):1431-1432]. Curr Med Res Opin. 2005;21(7): 1131-1137.
6. Durrie DS, Kennard MG, Boghossian AJ. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). Adv Ther. 2007; 24(6):1278-1285.
7. Gills JP. Voltaren associated with medication keratitis. J Cataract Refract Surg. 1994;20(1):110.
8. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108(5):936-944.
9. Probst LE, Machat JJ. Corneal subepithelial infiltrates following photorefractive keratectomy. J Cataract Refract Surg. 1996;22(3):281.
10. Sher NA, Krueger RR, Teal P, Jans RG, Edmison D. Role of topical corticosteroids and nonsteroidal anti-inflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy. J Refract Corneal Surg. 1994;10(5):587-588.
11. Shimazaki J, Saito H, Yang HY, Toda I, Fujishima H, Tsubota K. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea. 1995;14(6):623-627.
12. Trattler W, McDonald M. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Cornea. 2007;26(6):665-669.
13. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Ophthalmology. 2000;107(7):1224-1226.
14. Gaynes BI, Onyekwuluje A. Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension. Clin Ophthalmol. 2008; 2(2):355-368.
15. Reviglio VE, Rana TS, Li QJ, Ashraf MF, Daly MK, O'Brien TP. Effects of topical nonsteroidal anti-inflammatory drugs on the expression of matrix metalloproteinases in the cornea. J Cataract Refract Surg. 2003;29(5):989-997.
16. Garrett Q, Simmons PA, Xu S, et al. Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2007;48(4): 1559-1567.
17. Sasaki H, Yamamura K, Mukai T, et al. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle. Biol Pharm Bull. 2000;23(11):1352-1356.
18. Xu KP, Ding Y, Ling J, Dong Z, Yu FS. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45(3):813-820.
19. Xu KP, Li Y, Ljubimov AV, Yu FS. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes. 2009;58(5):1077-1085.
20. Richardson KC, Jarett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 1960;35: 313-323.
21. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001;99: 205-210.
22. Vennstrom L, Bysell C, Bjorkelund H, Lundqvist H, Andersson K. Real-time viability assay based on 51Cr retention in adherent cells. Biotechniques. 2008;44(2):237-240.
23. Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Experiment Ophthalmol. 2004;32(2):180-184.
24. Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009;25(5):415-424.
25. Kusano M, Uematsu M, Kumagami T, Sasaki H, Kitaoka T. Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo. Cornea. 2010;29(1):80-85.
26. Garrett Q, Xu S, Simmons PA, et al. Carboxymethyl cellulose stimulates rabbit corneal epithelial wound healing. Curr Eye Res. 2008; 33(7):567-573.
27. Donnenfeld ED, Holland EJ, Durrie DS, Raizman MB. Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. Adv Ther. 2007;24(4):852-862.